Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Sarcoma, Ewing 1 Recurrence 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 16 Temozolomide 13 Vincristine 10 Irinotecan 8 Melphalan 7 Doxorubicin 7 Topotecan 6 Granulocyte Colony-Stimulating Factor 6 Busulfan 6 fludarabine 5 cabozantinib 5 Etoposide 5 Drug Therapy 5 liposomal doxorubicin 4 Sirolimus 4 Ifosfamide 4 Filgrastim 4 regorafenib 3 pegfilgrastim 3 irinotecan sucrosofate 3 fludarabine phosphate 3 Zoledronic Acid 3 Radiotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Gemcitabine 3 Cisplatin 3 Bone Marrow Transplantation 3 Albumin-Bound Paclitaxel 3 pegylated granulocyte colony-stimulating factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sarcoma, Ewing × rubitecan × Clear all

NCT00492141 2012-08-02

Aerosol L9-NC and Temozolomide in Ewing's Sarcoma

M.D. Anderson Cancer Center

Phase 1/2 Completed

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡